Keyphrases
Tolvaptan
100%
Acute Decompensated Heart Failure
100%
Sodium Phosphate
100%
Congestion
33%
Congestive Heart Failure
33%
Oral Intake
33%
Phosphate Treatment
33%
Japan
16%
Clinical Data
16%
Heart Failure Patients
16%
Tokyo
16%
Retrospective Analysis
16%
Real-world Clinical Practice
16%
Hospitalized Patients
16%
Routine Clinical Practice
16%
Diuretics
16%
Hypernatremia
16%
Inotropes
16%
Urine Volume
16%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
16%
Continuous Hemodiafiltration
16%
Urine Osmolality
16%
Conventional Diuretics
16%
Aquaretic
16%
Unstable Hemodynamics
16%
Academic Medical Centers
16%
Noninvasive Positive Pressure Ventilation
16%
Medicine and Dentistry
Tolvaptan
100%
Decompensated Heart Failure
100%
Sodium Dihydrogen Phosphate
100%
Diuretic Agent
33%
Congestive Heart Failure
33%
Hemodynamic
16%
Amino Terminal Sequence
16%
Brain Natriuretic Peptide
16%
Continuous Positive Airway Pressure
16%
Hypernatremia
16%
Inotropic Agent
16%
Continuous Hemodiafiltration
16%
Hospital Inpatient
16%
Amiloride Plus Hydrochlorothiazide
16%